| Dr Timothy Erik Gundlach, MD | |
|
975 Port Washington Rd, Grafton, WI 53024-9201 | |
| (262) 329-2135 | |
| (262) 329-3151 |
| Full Name | Dr Timothy Erik Gundlach |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 39 Years |
| Location | 975 Port Washington Rd, Grafton, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144200205 | NPI | - | NPPES |
| 1144200205 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 33876-020 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aurora Medical Center - Grafton | Grafton, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aurora Medical Group, Inc. | 6709794258 | 3207 |
News Archive
AstraZeneca and POZEN Inc. today announced the U.S. Food and Drug Administration has approved VIMOVO (naproxen and esomeprazole magnesium) delayed-release tablets for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, and to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers.
The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2018) demonstrate that canakinumab significantly reduced the rate of gout by more than half compared to placebo, regardless of baseline serum urate level.
Antimicrobial peptides (AMPs) are molecules produced in the skin to fend off infection-causing microbes. Vitamin D has been credited with a role in their production and in the body's overall immune response, but scientists at the University of California, San Diego School of Medicine say a hormone previously associated only with maintaining calcium homeostasis and bone health is also critical, boosting AMP expression when dietary vitamin D levels are inadequate.
IN the UK alone, an estimated 7.8 million people have their lives blighted by chronic pain, and 44 per cent are failing to receive an accurate diagnosis and appropriate treatment. Now, a University of Huddersfield scientist, backed by funding from the British Pain Society and crucial support from the National Institute of Health Research, is embarking on research which aims to help doctors diagnose and treat one of the least understood but most widespread sources of chronic suffering.
› Verified 4 days ago
| Entity Name | Aurora Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427271378 PECOS PAC ID: 6709794258 Enrollment ID: O20031105000725 |
News Archive
AstraZeneca and POZEN Inc. today announced the U.S. Food and Drug Administration has approved VIMOVO (naproxen and esomeprazole magnesium) delayed-release tablets for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, and to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers.
The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2018) demonstrate that canakinumab significantly reduced the rate of gout by more than half compared to placebo, regardless of baseline serum urate level.
Antimicrobial peptides (AMPs) are molecules produced in the skin to fend off infection-causing microbes. Vitamin D has been credited with a role in their production and in the body's overall immune response, but scientists at the University of California, San Diego School of Medicine say a hormone previously associated only with maintaining calcium homeostasis and bone health is also critical, boosting AMP expression when dietary vitamin D levels are inadequate.
IN the UK alone, an estimated 7.8 million people have their lives blighted by chronic pain, and 44 per cent are failing to receive an accurate diagnosis and appropriate treatment. Now, a University of Huddersfield scientist, backed by funding from the British Pain Society and crucial support from the National Institute of Health Research, is embarking on research which aims to help doctors diagnose and treat one of the least understood but most widespread sources of chronic suffering.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Timothy Erik Gundlach, MD 975 Port Washington Rd, Grafton, WI 53024-9201 Ph: (262) 329-2135 | Dr Timothy Erik Gundlach, MD 975 Port Washington Rd, Grafton, WI 53024-9201 Ph: (262) 329-2135 |
News Archive
AstraZeneca and POZEN Inc. today announced the U.S. Food and Drug Administration has approved VIMOVO (naproxen and esomeprazole magnesium) delayed-release tablets for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, and to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers.
The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2018) demonstrate that canakinumab significantly reduced the rate of gout by more than half compared to placebo, regardless of baseline serum urate level.
Antimicrobial peptides (AMPs) are molecules produced in the skin to fend off infection-causing microbes. Vitamin D has been credited with a role in their production and in the body's overall immune response, but scientists at the University of California, San Diego School of Medicine say a hormone previously associated only with maintaining calcium homeostasis and bone health is also critical, boosting AMP expression when dietary vitamin D levels are inadequate.
IN the UK alone, an estimated 7.8 million people have their lives blighted by chronic pain, and 44 per cent are failing to receive an accurate diagnosis and appropriate treatment. Now, a University of Huddersfield scientist, backed by funding from the British Pain Society and crucial support from the National Institute of Health Research, is embarking on research which aims to help doctors diagnose and treat one of the least understood but most widespread sources of chronic suffering.
› Verified 4 days ago
Man Dick Young, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 975 Port Washington Rd, Grafton, WI 53024 Phone: 262-329-2135 Fax: 262-329-3151 | |
Dr. Ali A Sadeghi, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 975 Port Washington Rd, Grafton, WI 53024 Phone: 414-219-2000 | |
Dr. Robert J Schlosser, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 975 Port Washington Rd, Grafton, WI 53024 Phone: 262-329-1000 Fax: 262-329-1001 | |
Jeremy M Groth, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 975 Port Washington Rd, Grafton, WI 53024 Phone: 262-329-1000 Fax: 262-329-1001 | |
Joseph Doherty, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 975 Port Washington Rd, Grafton, WI 53024 Phone: 262-329-1000 Fax: 262-329-1001 | |
Dr. Chad G Vanden Heuvel, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 975 Port Washington Rd, Grafton, WI 53024 Phone: 262-329-1000 Fax: 262-329-1001 |